Related Experiment Video
Updated: Jul 21, 2025

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Perinatal Depression: A Review and an Update.
Anne Louise Stewart1, Jennifer L Payne1
1Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, PO Box 800548, Charlottesville, VA 22908, USA.
Perinatal depression significantly impacts maternal and infant health. Routine screening and treatment, including medication and non-pharmacological options, are recommended for pregnant and postpartum women.
Area of Science:
- Perinatal psychiatry
- Maternal-fetal medicine
- Neuropharmacology
Background:
- Perinatal depression is a prevalent psychiatric disorder affecting pregnant and postpartum individuals.
- Untreated maternal depression poses risks to both the mother and the developing infant.
- Early identification and intervention are crucial for positive outcomes.
Purpose of the Study:
- To emphasize the importance of routine screening for perinatal depression.
- To review the risk-benefit analysis of antidepressant use during pregnancy and lactation.
- To discuss current and emerging treatment strategies for perinatal depression.
Main Methods:
- Literature review on perinatal depression screening and management.
- Analysis of risk-benefit profiles for pharmacotherapy in pregnancy and lactation.
- Exploration of non-pharmacological and novel pharmacological interventions.
Main Results:
- Screening for perinatal depression is feasible and should be integrated into routine care.
- The benefits of treating maternal depression often outweigh the risks associated with necessary medications.
- New treatments targeting the GABAergic system show promise.
Conclusions:
- Routine screening and timely treatment are essential for managing perinatal depression.
- Antidepressant use during pregnancy and lactation is generally favorable compared to untreated depression.
- Advancements in treatment, including novel GABAergic agents, offer new therapeutic avenues.
Related Concept Videos
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Long-term Depression
Depressive Disorders: MDD and Dysthymia
Diagnostic and Statistical Manual of Mental Disorders (DSM)

